A SYSTEMS PHARMACOLOGY MODEL TO EVALUATE TRIPLE DRUG COMBINATION THERAPY AT OVERCOMING RESISTANCE TO ANTI-HER2 THERAPY IN HER2-POSITIVE BREAST CANCER.

Franco Y.; Ramakrishnan V.; Vaidya T.; Ait-Oudhia S.

首页> 外文期刊>Clinical Pharmacology and Therapeutics >A SYSTEMS PHARMACOLOGY MODEL TO EVALUATE TRIPLE DRUG COMBINATION THERAPY AT OVERCOMING RESISTANCE TO ANTI-HER2 THERAPY IN HER2-POSITIVE BREAST CANCER.

【24h】

A SYSTEMS PHARMACOLOGY MODEL TO EVALUATE TRIPLE DRUG COMBINATION THERAPY AT OVERCOMING RESISTANCE TO ANTI-HER2 THERAPY IN HER2-POSITIVE BREAST CANCER.

机译：一种系统药理学模型，评价三重药物联合治疗在耐乳癌抗Her2疗法耐抗Her2疗法中的抗性。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical Pharmacology and Therapeutics》 |2020年第s1期|共1页
作者
Franco Y.; Ramakrishnan V.; Vaidya T.; Ait-Oudhia S.;
展开▼
作者单位

Univ Florida Orlando FL USA;

Univ Buffalo Buffalo NY USA;

Univ Florida Orlando FL USA;

Univ Florida Orlando FL USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词

相似文献

外文文献
中文文献
专利

1. A SYSTEMS PHARMACOLOGY MODEL TO EVALUATE TRIPLE DRUG COMBINATION THERAPY AT OVERCOMING RESISTANCE TO ANTI-HER2 THERAPY IN HER2-POSITIVE BREAST CANCER. [J] . Franco Y., Ramakrishnan V., Vaidya T., Clinical Pharmacology and Therapeutics . 2020,第S1期

机译：一种系统药理学模型，评价三重药物联合治疗在耐乳癌抗Her2疗法耐抗Her2疗法中的抗性。
2. SYSTEMS PHARMACOLOGICAL ANALYSIS OF A TUMOR PRIMING COMBINATION THERAPY TO OVERCOME HER2 AND MTOR THERAPIES RESISTANCE IN BREAST CANCER. [J] . Vaidya T., Ande A., Nguyen Tran B., Clinical Pharmacology and Therapeutics . 2018,第Suppla1期

机译：肿瘤灌注组合疗法的系统药理分析克服HER2和MTOR治疗乳腺癌的抵抗力。
3. HSA-based multi-target combination therapy: regulating drugs’ release from HSA and overcoming single drug resistance in a breast cancer model [J] . Yi Gou, Zhenlei Zhang, Dongyang Li, Drug delivery. . 2018,第1期

机译：基于HSA的多目标联合疗法：在乳腺癌模型中调节药物从HSA的释放并克服单一耐药性
4. Overcoming therapeutic resistance in pancreatic cancer is not a simple mix of PDT and chemotherapy: Evaluation of PDT-chemotherapy combinations in 3D tumor models [C] . Jonathan P. Celli, Ljubica Petrovic, Iqbal Massodi, Optical methods for tumor treatment and detection: mechanisms and techniques in photodynamic therapy XXII . 2013

机译：克服胰腺癌的治疗抗性不是PDT和化学疗法的简单组合：在3D肿瘤模型中评估PDT-化学疗法的组合
5. Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance. [D] . Khdair, Ayman Abed. 2008

机译：纳米粒子介导的化学疗法和光动力疗法相结合，克服了肿瘤的耐药性。
6. Utility of a Novel Three-Dimensional and Dynamic (3DD) Cell Culture System for PK/PD Studies: Evaluation of a Triple Combination Therapy at Overcoming Anti-HER2 Treatment Resistance in Breast Cancer [O] . Anusha Ande, Tanaya R. Vaidya, Bao N. Tran, 2018

机译：新型的三维和动态（3DD）细胞培养系统用于PK / PD研究的效用：评估三联疗法克服乳腺癌中抗HER2治疗的耐药性
7. Utility of a Novel Three-Dimensional and Dynamic (3DD) Cell Culture System for PK/PD Studies: Evaluation of a Triple Combination Therapy at Overcoming Anti-HER2 Treatment Resistance in Breast Cancer [O] . Anusha Ande, Tanaya R. Vaidya, Bao N. Tran, 2018

机译：PK / PD研究新型三维和动态（3DD）细胞培养系统的效用：评估三重组合治疗在克服乳腺癌中的抗HER2治疗抵抗力
8. Combination Immunotherapy for the Treatment of High-Risk HER2-Positive Breast Cancer. [R] . Mittendorf, E. A. 2015

机译：联合免疫治疗高危HER2阳性乳腺癌。

A SYSTEMS PHARMACOLOGY MODEL TO EVALUATE TRIPLE DRUG COMBINATION THERAPY AT OVERCOMING RESISTANCE TO ANTI-HER2 THERAPY IN HER2-POSITIVE BREAST CANCER.

著录项

相似文献

相关主题

期刊订阅